2D vs 3D published_AES 2022.pdf (783.19 kB)
Download file

2D and 3D in-vitro models for mimicking cardiac physiology

Download (783.19 kB)
journal contribution
posted on 15.09.2022, 16:19 authored by Gerges Abdelsayed, Danish Ali, Andrew MaloneAndrew Malone, Jemil SaidiJemil Saidi, Manoj Myneni, Keshava Rajagopal, Faisal H Cheema, Aamir HameedAamir Hameed
Cardiovascular diseases are the leading cause of morbidity and mortality and a huge economic burden on the healthcare system globally. Both pharmacological and device based treatment options have emerged over the years, however, it is still a ‘holy grail’ to effectively treat some cardiovascular conditions, for example, heart failure. Any treatment option whether it is drug therapy or a device therapy, has to go through a rigorous regulatory approval process. This requires robust pre-clinical research and clinical trial results. In order to proceed to the clinical trials, pre-clinical research is very important and may take methodologies which are at the interface of biology and engineering, for example, in-vitro, ex-vivo and in-vivo models. This paper focusses on the 2D and 3D in-vitro models to mimic the pathophysiology of a specific cardiovascular disease and their advantages and limitations.

History

Comments

The original article is available at https://www.sciencedirect.com/

Published Citation

Abdelsayed G, et al. 2D and 3D in-vitro models for mimicking cardiac physiology. Applications in Engineering Science. 2022;12:100115.

Publication Date

28 August 2022

Department/Unit

  • Anatomy and Regenerative Medicine
  • Tissue Engineering Research Group (TERG)
  • Undergraduate Research

Research Area

  • Biomaterials and Regenerative Medicine
  • Health Professions Education
  • Surgical Science and Practice

Publisher

Elsevier BV

Version

  • Published Version (Version of Record)